Nightingale Health Plc – Managers' Transactions – 17 September 2021 8.00 a.m. (EEST)

____________________________________________

Person subject to the notification requirement

Name: Soininen, Timo

Position: Member of the Board/Deputy member

Issuer: Nightingale Health Oyj

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 743700WUIPC24LVMLO66_20210916201315_2

____________________________________________

Transaction date: 2021-09-16

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 23,021 Unit price: 4.124 EUR

(2): Volume: 190 Unit price: 4.118 EUR

(3): Volume: 8 Unit price: 4.118 EUR

(4): Volume: 281 Unit price: 4.118 EUR

(5): Volume: 1,169 Unit price: 4.118 EUR

(6): Volume: 331 Unit price: 4.118 EUR

Aggregated transactions

(6): Volume: 25,000 Volume weighted average price: 4.12353 EUR

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. By combining our pioneering blood-testing technology and the ability to detect future disease risks, we are creating a world-leading health data platform that enables preventative care with better information. The platform helps people make better personal health decisions and connects the health industry to offer their services for individuals’ preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.